SOL [ReneSola] 6-K: (Original Filing)
[]
[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE LETTER DUE TO DELAY IN FILING FORM 10-Q Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (the “Company”), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that on August 19, 2015, the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that because it] []
[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE LETTER DUE TO DELAY IN FILING FORM 10-Q Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (the “Company”), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that on August 19, 2015, the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that because it] []
[ReneSola Ltd Announces Second Quarter 2015 Results SHANGHAI, China, August 25, 2015 www.renesola.com Second Quarter 2015 Financial and Operating Highlights • Total solar module shipments were 322.0 megawatts (“MW”), representing a decrease of 35.1% from Q1 2015. Total solar wafer and module shipments in Q2 2015 were 603.7MW, compared to 691.5MW in Q1 2015, and 698.3MW in Q2 2014. •] []
[* 13D CUSIP No. 71372U104 1 NAMES OF REPORTING PERSONS Farallon Capital Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ]]
[ReneSola Ltd Announces Second Quarter 2015 Results SHANGHAI, China, August 25, 2015 www.renesola.com Second Quarter 2015 Financial and Operating Highlights • Total solar module shipments were 322.0 megawatts (“MW”), representing a decrease of 35.1% from Q1 2015. Total solar wafer and module shipments in Q2 2015 were 603.7MW, compared to 691.5MW in Q1 2015, and 698.3MW in Q2 2014. •] []
[* 13D CUSIP No. 71372U104 1 NAMES OF REPORTING PERSONS Farallon Capital Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ]]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer Taiwan Semiconductor Manufacturing Company Limited 1) The changes in the shareholdings of our board directors, executive officers and shareholders who own more than 10% of total outstanding common shares: Number of shares held as of]
[This Form 6-K consists of: ISSUE OF SHORT-TERM DEBENTURES Listing Rules Company As resolved at the 2014 annual general meeting of Huaneng Power International, Inc. (the “ Debentures The Company has recently completed the issue of the second tranche of the Company’s short-term debentures for 2015 (the “ Bank of China Limited acts as the lead underwriter to form the]